These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 12598827

  • 1. Recommendations for the prevention and management of tuberculosis in patients taking infliximab.
    Salmon-Ceron D, Groupe Recherche Anti-TNF et Infections Opportunistes, Agence Française de Sécurité Sanitaire des Produits de Santé.
    Ann Med Interne (Paris); 2002 Nov; 153(7):429-31. PubMed ID: 12598827
    [Abstract] [Full Text] [Related]

  • 2. Recommendations about the prevention and management of tuberculosis in patients taking infliximab.
    Salmon D, GTI and AFSSAPS. Groupe Tuberculose et infliximab. Agence Française de Sécurité Sanitaire de Produits de Santé.
    Joint Bone Spine; 2002 Mar; 69(2):170-2. PubMed ID: 12027307
    [Abstract] [Full Text] [Related]

  • 3. [Case of miliary tuberculosis during treatment with infliximab for rheumatoid arthritis].
    Taniguchi H, Izumi S.
    Kekkaku; 2008 May; 83(5):431-4. PubMed ID: 18536334
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Suspected cases of severe side effects after infliximab (Remicade) in Germany].
    Andus T, Stange EF, Höffler D, Keller-Stanislawski B.
    Med Klin (Munich); 2003 Aug 15; 98(8):429-36. PubMed ID: 12928808
    [Abstract] [Full Text] [Related]

  • 8. Tuberculosis following therapy with infliximab may be refractory to antibiotic therapy.
    Taylor JC, Orkin R, Lanham J.
    Rheumatology (Oxford); 2003 Jul 15; 42(7):901-2. PubMed ID: 12826707
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Development of fatal tuberculosis in a patient with rheumatoid arthritis after three years of treatment with infliximab: comment on the article by Wolfe et al.
    Molenaar ET, Bultink IE, Dijkmans BA, Lems WF.
    Arthritis Rheum; 2005 Apr 15; 52(4):1334-6. PubMed ID: 15818690
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Immunosuppressive therapy and tuberculosis].
    Yoshikawa K, Yano S.
    Kekkaku; 2010 Jan 15; 85(1):33-45. PubMed ID: 20232543
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.